1. Home
  2. SRRK vs LEU Comparison

SRRK vs LEU Comparison

Compare SRRK & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • LEU
  • Stock Information
  • Founded
  • SRRK 2012
  • LEU 1998
  • Country
  • SRRK United States
  • LEU United States
  • Employees
  • SRRK N/A
  • LEU N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • SRRK Health Care
  • LEU Industrials
  • Exchange
  • SRRK Nasdaq
  • LEU Nasdaq
  • Market Cap
  • SRRK 3.2B
  • LEU 3.1B
  • IPO Year
  • SRRK 2018
  • LEU 1998
  • Fundamental
  • Price
  • SRRK $37.44
  • LEU $201.89
  • Analyst Decision
  • SRRK Strong Buy
  • LEU Strong Buy
  • Analyst Count
  • SRRK 6
  • LEU 10
  • Target Price
  • SRRK $42.17
  • LEU $171.67
  • AVG Volume (30 Days)
  • SRRK 1.4M
  • LEU 1.4M
  • Earning Date
  • SRRK 08-07-2025
  • LEU 08-05-2025
  • Dividend Yield
  • SRRK N/A
  • LEU N/A
  • EPS Growth
  • SRRK N/A
  • LEU 40.85
  • EPS
  • SRRK N/A
  • LEU 6.39
  • Revenue
  • SRRK N/A
  • LEU $471,400,000.00
  • Revenue This Year
  • SRRK N/A
  • LEU $3.22
  • Revenue Next Year
  • SRRK $502.60
  • LEU $9.91
  • P/E Ratio
  • SRRK N/A
  • LEU $32.28
  • Revenue Growth
  • SRRK N/A
  • LEU 58.72
  • 52 Week Low
  • SRRK $6.76
  • LEU $33.51
  • 52 Week High
  • SRRK $46.98
  • LEU $211.31
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 59.82
  • LEU 69.05
  • Support Level
  • SRRK $33.60
  • LEU $167.26
  • Resistance Level
  • SRRK $38.15
  • LEU $188.50
  • Average True Range (ATR)
  • SRRK 1.91
  • LEU 16.92
  • MACD
  • SRRK 0.21
  • LEU -0.79
  • Stochastic Oscillator
  • SRRK 89.12
  • LEU 91.87

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

Share on Social Networks: